| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/03/2004 | US20040106567 inhibiting expression of a gene in an extravascular mammalian cell by: a) injecting a naked polynucleotide into a blood vessel lumen; b) increasing permeability in the vessel; and, c) delivering the polynucleotide to an extravascular cell |
| 06/03/2004 | US20040106566 RNA-splicing and processing-directed gene silencing and the relative applications thereof |
| 06/03/2004 | US20040106565 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
| 06/03/2004 | US20040106564 Use of slpi for treating chronic inflammatory intestinal diseases |
| 06/03/2004 | US20040106555 Neurogenin3 and production of pancreatic islet cells |
| 06/03/2004 | US20040106540 Method of treating cancer |
| 06/03/2004 | US20040106200 Whole-body optical imaging of gene expression and uses thereof |
| 06/03/2004 | US20040106198 Inhibition of peptide cleavage in plants |
| 06/03/2004 | US20040106194 Genetically engineered gene transfer vector comprising mutiple viral serotype sequences and E4 region of preferential virus for use as transfer tool in gene therapy and vaccine preparation |
| 06/03/2004 | US20040106193 Novel adenoviral vector and methods for making and using the same |
| 06/03/2004 | US20040106181 Novel isoform of human camp-dependent protein kinase, calpha -s , localizes to sperm mid-piece and the use thereof |
| 06/03/2004 | US20040106177 Biocatalytic oxidation, carboxylation, hydrolysis in a culture, using recombinant xylene monooxygenase, expressed by transformed microorganisms; producing substituted benzyl alcohol, benzaldehyde and benzoic acid, as chemical intermediates |
| 06/03/2004 | US20040106176 Biosynthesis of polylactones, using an organism genes expressing synthase, biocatalysis, forming biocompatible films, latexes, coatings, adhesives, fibers, binders, medical devices, for therapeutic controlled release, tissue engineering scaffolds |
| 06/03/2004 | US20040106175 Methods of producing polyketide synthase mutants and compositions and uses thereof |
| 06/03/2004 | US20040106174 Designing immunogens |
| 06/03/2004 | US20040106171 Peptides with anti-hypertensive properties |
| 06/03/2004 | US20040106160 Screening assay for antagonists of human leukocyte receptors |
| 06/03/2004 | US20040106154 In vivo screen using chemical inducers of dimerization |
| 06/03/2004 | US20040106149 Novel gpcr hfrbn63 |
| 06/03/2004 | US20040106145 Method and apparatus for the automated generation of nucleic acid ligands |
| 06/03/2004 | US20040106140 comprising selection or isolation of heteroduplexes containing at least one internal single stranded region with a single stranded trap, using Recognition Element that is benzoylated-naphthoylated-DEAE-cellulose |
| 06/03/2004 | US20040106134 Comprises genetically engineered immunoglobulin for use in the treatment of bone disorders |
| 06/03/2004 | US20040106133 Method for detecting ammonia-oxidizing bacteria |
| 06/03/2004 | US20040106129 Mass spectrometric methods for biomolecular screening |
| 06/03/2004 | US20040106127 Comprises nucleotide sequences coding human adult and embryonic whole brain polypeptides; microarry for genome analysis; proteomics |
| 06/03/2004 | US20040106123 Regulation of human g protein-coupled receptor |
| 06/03/2004 | US20040106122 Expression vector coding heterologous enzymatic polypeptide and regulatory sequences from fatty acid elongase (FAE) for use as gene transfer tool in plant tissue engineering; disease resistant plants |
| 06/03/2004 | US20040106120 Identifying nucleotide sequence changes/polymorphism associated with abnormal cell adhesion and treating skin, asthma and chronic obstruction pulmonary disease using enzyme inhibitors |
| 06/03/2004 | US20040106118 Preparing transgenic vectors capable of transformation, propagation and expression of cell surface ligand binding activity in host cells; drug screening |
| 06/03/2004 | US20040106115 Sodium channel (rnav1.5a) and use thereof |
| 06/03/2004 | US20040106108 Solid support assay systems and methods utilizing non-standard bases |
| 06/03/2004 | US20040106106 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 06/03/2004 | US20040106105 Vaccine |
| 06/03/2004 | US20040106100 Dna vaccines encoding hiv accessory proteins |
| 06/03/2004 | US20040105871 Pox viral vector plasmid construct comprising a vaccine insert that encodes at least two antigens; DNA-based vaccine can be tailored for the type of immune response that will be mobilized |
| 06/03/2004 | US20040105865 Treatment and diagnosis of prostate cancer |
| 06/03/2004 | US20040105862 Human TIMP-1 antibodies |
| 06/03/2004 | US20040105857 Methods and compositions for enhancing angiogenesis |
| 06/03/2004 | US20040105855 Compries immunoglobulin which binds tumor necrosis factor receptor and functions as antitumor agent in the treatment of cancer |
| 06/03/2004 | US20040105854 monoclonal or polyclonal antibodies with histidine polypeptides for immunization |
| 06/03/2004 | US20040105853 controlling genes and metastasis in polynucleotides for infections |
| 06/03/2004 | US20040105845 Delivering a genetic sequence to cells for gene therapy |
| 06/03/2004 | US20040105844 transfecting herpes simplex virus host cells with ampliicons by genetic engineering packaging a signal and expression vectors |
| 06/03/2004 | US20040105841 Interferons, uses and compositions related thereto |
| 06/03/2004 | DE10254652A1 Knock-in mouse, useful in screening agents for treatment of epilepsy, contains a missense mutation in the beta2-subunit of the neuronal acetylcholine receptor |
| 06/03/2004 | DE10254166A1 Verfahren zur Kontrolle eines zellulären Prozesses in Pflanzen A method for controlling a cellular process in plants |
| 06/03/2004 | DE10254165A1 Verfahren zur Kontrolle eines zellulären Prozesses in einem multizellulären Organismus A method for controlling a cellular process in a multicellular organism |
| 06/03/2004 | DE10253112A1 Production of ketocarotenoids with low hydroxylated by-product content, for use e.g. in pigmenting feedstuffs, by culturing genetically modified organisms having modified ketolase activity |
| 06/03/2004 | DE10246384A1 Fractionating nucleic acid into sequence-specific subgroups, useful for e.g. displaying DNA fragment subsets, by treatment with type IIs restriction enzyme, attaching adapter then selective amplification |
| 06/03/2004 | CA2847795A1 Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 06/03/2004 | CA2599222A1 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll) |
| 06/03/2004 | CA2506894A1 Method of isolating nucleic acid having desired functional property and kit therefor |
| 06/03/2004 | CA2506737A1 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll) |
| 06/03/2004 | CA2506724A1 Antibodies, polypeptides and uses thereof |
| 06/03/2004 | CA2506625A1 Autocrine growth factor receptor antibodies and methods |
| 06/03/2004 | CA2506581A1 Novel 2',5'-oligoadenylic acid analogues |
| 06/03/2004 | CA2506576A1 Amino-lna, thio-lna and alpha-l-oxy-ln |
| 06/03/2004 | CA2506547A1 Hydroxypyruvate reductase promoter elements and methods of use thereof in plants |
| 06/03/2004 | CA2506505A1 Antibodies lacking vacuolar targeting signal peptide and capable of binding j-chain |
| 06/03/2004 | CA2506331A1 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 06/03/2004 | CA2506246A1 Products and processes for modulating peptide-peptide binding domain interactions |
| 06/03/2004 | CA2506245A1 Exon 1.beta. of pdgf receptor .alpha. gene and utilization thereof |
| 06/03/2004 | CA2506243A1 Amplified genes involved in cancer |
| 06/03/2004 | CA2506128A1 Anti-activated ras antibodies |
| 06/03/2004 | CA2506127A1 Methods of generating high-production of antibodies from hybridomas created by in vitro immunization |
| 06/03/2004 | CA2506124A1 Intracellular antibodies |
| 06/03/2004 | CA2506058A1 Nucleic acid probes and broad-range primers from regions in topoisomerase genes, and methods in which they are used |
| 06/03/2004 | CA2506050A1 Methods, nucleic acid constructs and cells for treating neurodegenerative disorders |
| 06/03/2004 | CA2506031A1 Self-containing lactobacillus strain comprising a thya mutation and therapeutic applications thereof |
| 06/03/2004 | CA2505919A1 Ca125 gene and its use for diagnostic and therapeutic interventions |
| 06/03/2004 | CA2505721A1 Rnai-based sensors, caged interfering rnas, and methods of use thereof |
| 06/03/2004 | CA2505680A1 Inhibitory oliogonucleotides targeted to bcl-2 |
| 06/03/2004 | CA2505603A1 Caged sensors, regulators and compounds and uses thereof |
| 06/03/2004 | CA2505085A1 Production of increased oil and protein in plants by the disruption of the phenylpropanoid pathway |
| 06/03/2004 | CA2504715A1 Vaccine |
| 06/03/2004 | CA2504654A1 Vaccine against hcv |
| 06/03/2004 | CA2504595A1 Intron fusion construct and method of using for selecting high-expressing production cell lines |
| 06/03/2004 | CA2504267A1 Interferon-alpha polypeptides and conjugates |
| 06/03/2004 | CA2501232A1 Coronary artery disease treatment |
| 06/03/2004 | CA2497863A1 Method of controlling a cellular process in a multi-cellular organism |
| 06/03/2004 | CA2497851A1 Method of controlling cellular processes in plants |
| 06/03/2004 | CA2497558A1 Method of controlling gene expression in plants or plant cells |
| 06/03/2004 | CA2489360A1 Methods and compositions for determining methylation profiles |
| 06/03/2004 | CA2483870A1 Interacting site for gp41 on gp120 of hiv-1 |
| 06/02/2004 | EP1424559A1 Micro flow passage device, connection device, and method of using the devices |
| 06/02/2004 | EP1424401A1 METHOD OF DETECTING, IDENTIFYING AND COUNTING ENTERITIS VIBRIO USING GENE (rpoD) SEQUENCES ENCODING RNA POLYMERASE SIGMA 70 FACTOR |
| 06/02/2004 | EP1424398A2 Method for producing L-glutamine by fermentation and L-glutamine producing bacterium |
| 06/02/2004 | EP1424396A1 Sulfated fucogalactan digesting enzyme gene |
| 06/02/2004 | EP1424395A1 Tyrosyl-trna synthase variants |
| 06/02/2004 | EP1424394A2 TAT transdominant variants from HIV virus |
| 06/02/2004 | EP1424393A2 Mammalian cytokine-like polypeptide-10 |
| 06/02/2004 | EP1424392A1 Novel secretory proteins and dna thereof |
| 06/02/2004 | EP1424387A1 Method of extended culture for antigen-specific cytotoxic t lymphocytes |
| 06/02/2004 | EP1424344A1 Modified cDNA factor VIII and its derivates |
| 06/02/2004 | EP1424343A1 Peptide Conjugate useful for cell nucleus molecular imaging and tumor therapy |
| 06/02/2004 | EP1424342A1 Nucleic acid comprising a sequence encoding a modified glutenin polypeptide |
| 06/02/2004 | EP1423707A1 Methods of screening molecules that are used to prevent cardiovascular diseases |
| 06/02/2004 | EP1423704A1 Diagnostic and therapeutic use of f-box proteins for alzheimer's disease and related neurodegenerative disorders |
| 06/02/2004 | EP1423697A2 Secreted proteins |
| 06/02/2004 | EP1423695A2 Androgen receptor knock-out transgenic animals |